Aurora Spine Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference
21 September 2022 - 12:48AM
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:
ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative
medical devices that improve spinal surgery outcomes, today
announced that it will be participating in the Lytham Partners Fall
2022 Investor Conference, taking place virtually on September
28-29, 2022. During the event, the company will be participating in
a webcasted presentation discussion and conducting 1x1 virtual
investor meetings.
The Company’s webcast presentation will be a Panel
Discussion hosted by Trent Northcutt, President and CEO
and Krissy Ramey, National Director of Clinical Education of Aurora
Spine. The discussion is titled: Simplifying the Complex – A Panel
Discussion with Doctors that use Aurora Products, and will be
available for viewing at 9:00am ET on Wednesday, September 28,
2022, at https://wsw.com/webcast/lytham6/asg.v/2112539 or on the
Company's website. The webcast will also be archived and available
for replay.
Management will be participating in virtual one-on-one meetings
throughout the event. To arrange a meeting with management, please
contact Lytham Partners at 1x1@lythampartners.com or register at
www.lythampartners.com/fall2022invreg.
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal
implant market through a series of innovative, minimally invasive,
regenerative spinal implant technologies. Additional information
can be accessed at www.aurora-spine.com or
www.aurorapaincare.com.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that
involves substantial known and unknown risks and uncertainties,
most of which are beyond the control of Aurora Spine, including,
without limitation, those listed under "Risk Factors" and
"Cautionary Statement Regarding Forward-Looking Information" in
Aurora Spine's final prospectus (collectively, "forward-looking
information"). Forward-looking information in this news release
includes information concerning the proposed use and success of the
company’s products in surgical procedures. Aurora Spine cautions
investors of Aurora Spine's securities about important factors that
could cause Aurora Spine's actual results to differ materially from
those projected in any forward-looking statements included in this
news release. Any statements that express, or involve discussions
as to, expectations, beliefs, plans, objectives, assumptions or
future events or performance are not historical facts and may be
forward-looking and may involve estimates, assumptions and
uncertainties which could cause actual results or outcomes to
differ unilaterally from those expressed in such forward-looking
statements. No assurance can be given that the expectations set out
herein will prove to be correct and, accordingly, prospective
investors should not place undue reliance on these forward-looking
statements. These statements speak only as of the date of this
press release and Aurora Spine does not assume any obligation to
update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent NorthcuttPresident and Chief Executive Officer(760)
424-2004
Chad ClouseChief Financial Officer(760)
424-2004www.aurora-spine.com
Adam LowensteinerLytham Partners, LLCPhoenix | New
YorkTelephone: 646-829-9700asapf@lythampartners.com
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Apr 2023 to Apr 2024